Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125176652 | 12517665 | 2 | F | 20160527 | 20160628 | 20160630 | 20160706 | EXP | PHHY2016ES088690 | SANDOZ | 84.00 | YR | M | Y | 0.00000 | 20160706 | OT | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125176652 | 12517665 | 1 | SS | EUCREAS | METFORMIN HYDROCHLORIDEVILDAGLIPTIN | 1 | Oral | 1 DF (850 MG METF AND 50 MG VILD), BID | Y | 0 | 1 | DF | BID | ||||||
125176652 | 12517665 | 2 | SS | STALEVO | CARBIDOPAENTACAPONELEVODOPA | 1 | Oral | 1 DF (ENTACAPONE 200 MG, LEVODOPA 150 MG, CARBIDOPA 37.5 MG), QD | Y | 0 | 1 | DF | QD | ||||||
125176652 | 12517665 | 3 | PS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 10 MG, QD | Y | 77514 | 10 | MG | QD | ||||||
125176652 | 12517665 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, TID | Y | 0 | 150 | MG | TID | ||||||
125176652 | 12517665 | 5 | SS | NOVONORM | REPAGLINIDE | 1 | Oral | 1 MG, TID | Y | 0 | 1 | MG | TID | ||||||
125176652 | 12517665 | 6 | SS | PLETAL | CILOSTAZOL | 1 | Oral | 100 MG, BID | Y | 0 | 100 | MG | BID | ||||||
125176652 | 12517665 | 7 | SS | ROLPRYNA | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 8 MG, QD | Y | 0 | 8 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125176652 | 12517665 | 1 | Type 2 diabetes mellitus |
125176652 | 12517665 | 2 | Dementia |
125176652 | 12517665 | 3 | Hypertension |
125176652 | 12517665 | 4 | Product used for unknown indication |
125176652 | 12517665 | 5 | Type 2 diabetes mellitus |
125176652 | 12517665 | 6 | Product used for unknown indication |
125176652 | 12517665 | 7 | Dementia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125176652 | 12517665 | LT |
125176652 | 12517665 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125176652 | 12517665 | Atrial fibrillation | |
125176652 | 12517665 | Chest pain | |
125176652 | 12517665 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125176652 | 12517665 | 1 | 2016 | 201606 | 0 | |
125176652 | 12517665 | 2 | 2016 | 201606 | 0 | |
125176652 | 12517665 | 3 | 2016 | 201606 | 0 | |
125176652 | 12517665 | 4 | 2016 | 201606 | 0 | |
125176652 | 12517665 | 5 | 2016 | 201606 | 0 | |
125176652 | 12517665 | 6 | 2016 | 201606 | 0 | |
125176652 | 12517665 | 7 | 2016 | 201606 | 0 |